Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2008

View Archived Issues

Clinical data on besifloxacin in bacterial conjunctivitis reported

Neuronal nicotinic receptor ligands profiled at AstraZeneca

Novel analgesic agents imparted in recent Glenmark, Merck and GSK patents

New therapeutic agents for neurological disorders reported by Taisho and Novartis

Recent Kowa and AstraZeneca patents impart new treatments for respiratory and allergic disorders

Novartis provides update of recent pipeline activity

First-in-human results of NGF enhancer KRX-0501 for the treatment of neurological disorders

PF-00868554 active, well tolerated in double-blind HCV study

Advitech and Laboratoires Urgo sign collaboration agreement in wound healing

HCV candidate BMS-790052 well tolerated in proof-of-concept study

PRT-201 shows potential to improve arteriovenous fistula surgery results

Positive phase III results reported for JZP-6 in fibromyalgia

FDA accepts Vanda's resubmission of NDA for iloperidone

Arpida provides update on iclaprim's regulatory pathway

FDA grants approval to SuperGen to initiate clinical trials of Pim inhibitor SGI-1776

Synta initiates treatment of patients in phase I/II trial of elesclomol in prostate cancer

Biovitrum reports positive results from clinical trial of Sym-001 in HDN

EMEA advises Santhera of negative opinion for idebenone MAA in Friedreich's ataxia

Enrollment suspended following DMC review of phase III MONET trial of motesanib

Aastrom treats first patient in U.S. phase II IMPACT-DCM trial

Takeda submits European MAA for once-daily Competact formulation

Nplate receives positive CHMP opinion for MAA in Europe

RoActemra receives positive opinion in Europe for rheumatoid arthritis

Rasilez HCT receives positive CHMP opinion for treatment of high blood pressure

FDA approves tapentadol immediate-release tablets for acute pain

Invitrogen and Applied Biosystems complete merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...